Eli Lilly and Company broke ground on a $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley.
The site is one of 10 new U.S. manufacturing sites announced since 2020, and one of four dedicated to injectable medicines and devices. Part of the company’s $50 billion push to expand medicine production in the U.S., the Lehigh Valley site will add capacity for the next generation of treatments.
The new facility will create 850 high-wage jobs along with approximately 2,000 construction jobs as the site is built and brought online. The Lehigh Valley site, located in Fogelsville, Pennsylvania, is expected to be operational by 2031.
“Today marks another historic milestone in Pennsylvania’s thriving life sciences sector and reinforces my Administration’s commitment to advancing innovation, strengthening the economy, and creating good-paying jobs across the Commonwealth,” said Pennsylvania Governor Josh Shapiro.
Mark Goode to Receive Lifetime Achievement Award at Connect Industrial Midwest on Tuesday, March 2, 2027, at Joe’s Live in Rosemont. Following the presentation, Mark Goode will sit down for a special keynote interview with his son, Matt Goode.
The post Eli Lilly Breaks Ground on $3.5B Lehigh Valley Manufacturing Campus appeared first on Connect CRE.
